Trade Bayer AG - BAYN CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.15 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.019974% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.002248% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | EUR | ||||||||
Margin | 20% | ||||||||
Stock exchange | Germany | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Bayer AG ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 54.35 |
Open* | 54.2 |
1-Year Change* | -18.5% |
Day's Range* | 53.45 - 54.4 |
52 wk Range | 46.70-67.49 |
Average Volume (10 days) | 1.86M |
Average Volume (3 months) | 45.82M |
Market Cap | 52.48B |
P/E Ratio | 17.28 |
Shares Outstanding | 982.42M |
Revenue | 50.49B |
EPS | 3.09 |
Dividend (Yield %) | 4.4927 |
Beta | 1.22 |
Next Earnings Date | Aug 8, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
May 29, 2023 | 54.35 | -0.05 | -0.09% | 54.40 | 54.90 | 54.25 |
May 26, 2023 | 54.25 | 0.90 | 1.69% | 53.35 | 54.50 | 53.20 |
May 25, 2023 | 53.30 | -0.40 | -0.74% | 53.70 | 53.70 | 51.95 |
May 24, 2023 | 53.85 | 0.90 | 1.70% | 52.95 | 54.15 | 52.95 |
May 23, 2023 | 54.00 | 0.30 | 0.56% | 53.70 | 54.10 | 53.35 |
May 22, 2023 | 54.00 | -0.50 | -0.92% | 54.50 | 54.65 | 53.95 |
May 19, 2023 | 54.55 | 1.60 | 3.02% | 52.95 | 54.70 | 52.95 |
May 18, 2023 | 54.10 | 0.55 | 1.03% | 53.55 | 54.50 | 53.55 |
May 17, 2023 | 53.75 | 0.25 | 0.47% | 53.50 | 53.80 | 52.95 |
May 16, 2023 | 53.70 | 0.50 | 0.94% | 53.20 | 54.15 | 53.10 |
May 15, 2023 | 53.20 | -0.85 | -1.57% | 54.05 | 54.20 | 52.10 |
May 12, 2023 | 53.80 | 0.40 | 0.75% | 53.40 | 54.60 | 53.40 |
May 11, 2023 | 54.05 | -2.30 | -4.08% | 56.35 | 56.40 | 53.60 |
May 10, 2023 | 58.15 | -0.20 | -0.34% | 58.35 | 58.55 | 58.00 |
May 9, 2023 | 58.15 | -0.05 | -0.09% | 58.20 | 58.30 | 57.85 |
May 8, 2023 | 58.25 | -0.20 | -0.34% | 58.45 | 58.50 | 57.95 |
May 5, 2023 | 58.45 | 0.10 | 0.17% | 58.35 | 58.50 | 57.55 |
May 4, 2023 | 58.00 | 0.85 | 1.49% | 57.15 | 58.20 | 57.15 |
May 3, 2023 | 57.10 | -0.05 | -0.09% | 57.15 | 57.60 | 56.60 |
May 2, 2023 | 57.05 | -0.45 | -0.78% | 57.50 | 58.00 | 57.00 |
Bayer AG Events
Time (UTC) | Country | Event |
---|---|---|
Tuesday, June 20, 2023 | ||
Time (UTC) 17:00 | Country DE
| Event Bayer AG Crop Science Innovation Summit Bayer AG Crop Science Innovation SummitForecast -Previous - |
Wednesday, June 28, 2023 | ||
Time (UTC) 07:00 | Country DE
| Event Bayer AG Pharmaceuticals R&D Event Bayer AG Pharmaceuticals R&D EventForecast -Previous - |
Tuesday, August 8, 2023 | ||
Time (UTC) 05:30 | Country DE
| Event Q2 2023 Bayer AG Earnings Release Q2 2023 Bayer AG Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 50739 | 44081 | 41400 | 43545 | 36742 |
Revenue | 50739 | 44081 | 41400 | 43545 | 36742 |
Cost of Revenue, Total | 19871 | 16816 | 19138 | 17613 | 15381 |
Gross Profit | 30868 | 27265 | 22262 | 25932 | 21361 |
Total Operating Expense | 43727 | 40728 | 57569 | 39383 | 33288 |
Selling/General/Admin. Expenses, Total | 16919 | 15370 | 15980 | 16156 | 14881 |
Research & Development | 6572 | 5412 | 7126 | 5301 | 5105 |
Interest Expense (Income) - Net Operating | 499 | 42 | -54 | 183 | -4 |
Unusual Expense (Income) | 468 | 3484 | 15345 | 315 | -3600 |
Other Operating Expenses, Total | -602 | -396 | 34 | -185 | 1525 |
Operating Income | 7012 | 3353 | -16169 | 4162 | 3454 |
Interest Income (Expense), Net Non-Operating | -2209 | -1317 | -976 | -1052 | -1239 |
Other, Net | -133 | 10 | -105 | -257 | -329 |
Net Income Before Taxes | 4670 | 2046 | -17250 | 2853 | 1886 |
Net Income After Taxes | 4166 | 1022 | -15561 | 2410 | 1390 |
Minority Interest | -16 | -22 | -8 | -19 | -16 |
Net Income Before Extra. Items | 4150 | 1000 | -15569 | 2391 | 1374 |
Total Extraordinary Items | 0 | 5074 | 1700 | 321 | |
Net Income | 4150 | 1000 | -10495 | 4091 | 1695 |
Income Available to Common Excl. Extra. Items | 4150 | 1000 | -15569 | 2391 | 1374 |
Income Available to Common Incl. Extra. Items | 4150 | 1000 | -10495 | 4091 | 1695 |
Diluted Net Income | 4150 | 1000 | -10495 | 4091 | 1695 |
Diluted Weighted Average Shares | 982.42 | 982.42 | 982.42 | 981.69 | 940.76 |
Diluted EPS Excluding Extraordinary Items | 4.22426 | 1.01789 | -15.8476 | 2.4356 | 1.46052 |
Dividends per Share - Common Stock Primary Issue | 2.4 | 2 | 2 | 2.8 | 2.8 |
Diluted Normalized EPS | 8.12248 | 4.39197 | -1.24738 | 3.32619 | 3.46921 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total revenue | 14389 | 12000 | 11281 | 12819 | 14639 |
Revenue | 14389 | 12000 | 11281 | 12819 | 14639 |
Cost of Revenue, Total | 5733 | 4768 | 4247 | 5680 | 5176 |
Gross Profit | 8656 | 7232 | 7034 | 7139 | 9463 |
Total Operating Expense | 11416 | 10568 | 10082 | 12650 | 10427 |
Selling/General/Admin. Expenses, Total | 4052 | 4426 | 4079 | 4472 | 3945 |
Research & Development | 1571 | 1614 | 1576 | 1928 | 1454 |
Other Operating Expenses, Total | 60 | -240 | 180 | 570 | -148 |
Operating Income | 2973 | 1432 | 1199 | 169 | 4212 |
Interest Income (Expense), Net Non-Operating | -367 | -562 | -598 | -692 | -490 |
Net Income Before Taxes | 2606 | 870 | 601 | -523 | 3722 |
Net Income After Taxes | 2182 | 609 | 552 | -289 | 3294 |
Minority Interest | -4 | 2 | -6 | -9 | -3 |
Net Income Before Extra. Items | 2178 | 611 | 546 | -298 | 3291 |
Total Extraordinary Items | |||||
Net Income | 2178 | 611 | 546 | -298 | 3291 |
Income Available to Common Excl. Extra. Items | 2178 | 611 | 546 | -298 | 3291 |
Income Available to Common Incl. Extra. Items | 2178 | 611 | 546 | -298 | 3291 |
Diluted Net Income | 2178 | 611 | 546 | -298 | 3291 |
Diluted Weighted Average Shares | 982.42 | 982.42 | 982.42 | 982.42 | 982.388 |
Diluted EPS Excluding Extraordinary Items | 2.21697 | 0.62193 | 0.55577 | -0.30333 | 3.35 |
Dividends per Share - Common Stock Primary Issue | 0 | 2.4 | 0 | 0 | 0 |
Diluted Normalized EPS | 2.58431 | 2.40752 | 0.69881 | 1.09337 | 3.31397 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 37760 | 32578 | 35675 | 32439 | 31065 |
Cash and Short Term Investments | 10153 | 7739 | 11883 | 5404 | 5002 |
Cash & Equivalents | 5171 | 4564 | 4191 | 3185 | 4052 |
Short Term Investments | 4982 | 3175 | 7692 | 2219 | 950 |
Total Receivables, Net | 13450 | 12980 | 12157 | 14851 | 14137 |
Accounts Receivable - Trade, Net | 10312 | 10047 | 9552 | 11678 | 11714 |
Total Inventory | 13636 | 11314 | 10961 | 10650 | 11132 |
Prepaid Expenses | 297 | 307 | 314 | 290 | 344 |
Other Current Assets, Total | 224 | 238 | 360 | 1244 | 450 |
Total Assets | 124877 | 120241 | 116804 | 126174 | 126732 |
Property/Plant/Equipment, Total - Net | 13674 | 12688 | 11723 | 12479 | 12943 |
Property/Plant/Equipment, Total - Gross | 28337 | 26188 | 23646 | 24380 | 25458 |
Accumulated Depreciation, Total | -14663 | -13500 | -11923 | -11901 | -12515 |
Goodwill, Net | 39648 | 40106 | 36418 | 39126 | 38442 |
Intangibles, Net | 24183 | 26258 | 25424 | 34709 | 36696 |
Long Term Investments | 1486 | 1195 | 993 | 971 | 1586 |
Note Receivable - Long Term | 1808 | 2005 | 1506 | 1501 | 1500 |
Other Long Term Assets, Total | 6318 | 5411 | 5065 | 4949 | 4500 |
Total Current Liabilities | 35084 | 29403 | 36768 | 23215 | 23125 |
Accounts Payable | 7545 | 6792 | 5678 | 6426 | 6038 |
Accrued Expenses | 434 | 339 | 374 | 343 | 367 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 7539 | 3053 | 8359 | 1975 | 2958 |
Other Current Liabilities, Total | 19566 | 19219 | 22357 | 14471 | 13762 |
Total Liabilities | 86104 | 87221 | 86281 | 78921 | 80755 |
Total Long Term Debt | 33781 | 36478 | 33198 | 36907 | 37708 |
Long Term Debt | 32829 | 35549 | 32267 | 35955 | 37359 |
Capital Lease Obligations | 952 | 929 | 931 | 952 | 349 |
Deferred Income Tax | 727 | 931 | 1175 | 3755 | 4667 |
Minority Interest | 153 | 148 | 152 | 180 | 171 |
Other Liabilities, Total | 16359 | 20261 | 14988 | 14864 | 15084 |
Total Equity | 38773 | 33020 | 30523 | 47253 | 45977 |
Common Stock | 2515 | 2515 | 2515 | 2515 | 2387 |
Additional Paid-In Capital | 18261 | 18261 | 18261 | 18261 | 18388 |
Retained Earnings (Accumulated Deficit) | 17233 | 13345 | 13059 | 26151 | 25739 |
Total Liabilities & Shareholders’ Equity | 124877 | 120241 | 116804 | 126174 | 126732 |
Total Common Shares Outstanding | 982.424 | 982.424 | 982.424 | 982.424 | 932.552 |
Unrealized Gain (Loss) | 112 | 212 | 117 | 310 | 122 |
Other Equity, Total | 652 | -1313 | -3429 | 16 | -659 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 39623 | 37760 | 38412 | 39550 | 38246 |
Cash and Short Term Investments | 7975 | 10379 | 9074 | 8194 | 8194 |
Cash & Equivalents | 4854 | 5171 | 4361 | 3412 | 5785 |
Short Term Investments | 3121 | 5208 | 4713 | 4782 | 2409 |
Total Receivables, Net | 18114 | 13742 | 14747 | 18385 | 17824 |
Accounts Receivable - Trade, Net | 14559 | 10312 | 11000 | 14785 | 14601 |
Total Inventory | 13531 | 13636 | 12791 | 11371 | 10869 |
Other Current Assets, Total | 3 | 3 | 1800 | 1600 | 1359 |
Total Assets | 125052 | 124877 | 131010 | 128794 | 125782 |
Property/Plant/Equipment, Total - Net | 13312 | 13674 | 13921 | 13275 | 12786 |
Goodwill, Net | 39254 | 39648 | 43452 | 41583 | 39789 |
Intangibles, Net | 23352 | 24183 | 25997 | 25367 | 26066 |
Long Term Investments | 2806 | 2942 | 2937 | 2792 | 2677 |
Note Receivable - Long Term | 1188 | 1065 | 1130 | 1155 | 1323 |
Other Long Term Assets, Total | 5517 | 5605 | 5161 | 5072 | 4895 |
Total Current Liabilities | 34391 | 35084 | 33172 | 33643 | 31019 |
Accounts Payable | 6268 | 7545 | 6549 | 6097 | 5847 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 9728 | 7861 | 5331 | 6573 | 5899 |
Other Current Liabilities, Total | 18395 | 19678 | 21292 | 20973 | 19273 |
Total Liabilities | 84188 | 86104 | 89738 | 90775 | 88345 |
Total Long Term Debt | 33571 | 33791 | 39460 | 38061 | 36648 |
Long Term Debt | 33571 | 33791 | 39460 | 38061 | 36648 |
Deferred Income Tax | 714 | 727 | 657 | 836 | 926 |
Minority Interest | 153 | 153 | 195 | 185 | 170 |
Other Liabilities, Total | 15359 | 16349 | 16254 | 18050 | 19582 |
Total Equity | 40864 | 38773 | 41272 | 38019 | 37437 |
Common Stock | 2515 | 2515 | 2515 | 2515 | 2515 |
Additional Paid-In Capital | 18261 | 18261 | 18261 | 18261 | 18261 |
Retained Earnings (Accumulated Deficit) | 20088 | 17997 | 20496 | 17243 | 16661 |
Total Liabilities & Shareholders’ Equity | 125052 | 124877 | 131010 | 128794 | 125782 |
Total Common Shares Outstanding | 982.424 | 982.424 | 982.424 | 982.424 | 982.424 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 4166 | 1022 | -15561 | 2430 | 1390 |
Cash From Operating Activities | 7096 | 5128 | 4896 | 8187 | 7918 |
Cash From Operating Activities | 6503 | 3056 | 13259 | 5365 | 6241 |
Non-Cash Items | 521 | 795 | 1198 | 899 | -2580 |
Cash Taxes Paid | 2034 | 2159 | 1063 | 2561 | 2028 |
Cash Interest Paid | 1296 | 1227 | 1301 | 1517 | 1331 |
Changes in Working Capital | -4094 | 255 | 6000 | -507 | 2867 |
Cash From Investing Activities | -2381 | 855 | -4073 | -671 | -34152 |
Capital Expenditures | -2949 | -2611 | -2418 | -2650 | -2593 |
Other Investing Cash Flow Items, Total | 568 | 3466 | -1655 | 1979 | -31559 |
Cash From Financing Activities | -4220 | -5645 | 423 | -8389 | 23432 |
Financing Cash Flow Items | -1251 | -1200 | -1276 | -1478 | -966 |
Total Cash Dividends Paid | -1985 | -1993 | -2768 | -2615 | -2407 |
Issuance (Retirement) of Stock, Net | -10 | 0 | 8986 | ||
Issuance (Retirement) of Debt, Net | -974 | -2452 | 4467 | -4296 | 17819 |
Foreign Exchange Effects | 112 | 35 | -240 | 6 | -581 |
Net Change in Cash | 607 | 373 | 1006 | -867 | -3383 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 2182 | 4166 | 3557 | 3005 | 3294 |
Cash From Operating Activities | -3550 | 7096 | 4035 | 1381 | -723 |
Cash From Operating Activities | 1345 | 6503 | 4659 | 3562 | 1080 |
Non-Cash Items | 237 | 521 | 1195 | 696 | 376 |
Cash Taxes Paid | 531 | 2034 | 1342 | 968 | 442 |
Cash Interest Paid | 183 | 1296 | 869 | 614 | 173 |
Changes in Working Capital | -7314 | -4094 | -5376 | -5882 | -5473 |
Cash From Investing Activities | 1602 | -2381 | -2448 | -2029 | 742 |
Capital Expenditures | -466 | -2949 | -1625 | -899 | -349 |
Other Investing Cash Flow Items, Total | 2068 | 568 | -823 | -1130 | 1091 |
Cash From Financing Activities | 1662 | -4220 | -2079 | -739 | 1075 |
Financing Cash Flow Items | -183 | -1251 | -828 | -573 | -137 |
Issuance (Retirement) of Debt, Net | 1845 | -974 | 704 | 1785 | 1197 |
Foreign Exchange Effects | -31 | 112 | 293 | 238 | 132 |
Net Change in Cash | -317 | 607 | -199 | -1149 | 1226 |
Total Cash Dividends Paid | -1985 | -1970 | -1966 | ||
Issuance (Retirement) of Stock, Net | 0 | -10 | 15 | 15 | 15 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 3.1473 | 30920064 | 1392186 | 2023-04-11 | LOW |
MFS Investment Management | Investment Advisor/Hedge Fund | 3.0361 | 29826993 | 463404 | 2022-07-05 | LOW |
Harris Associates L.P. | Investment Advisor/Hedge Fund | 2.986 | 29334705 | -298339 | 2022-03-28 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.9158 | 28645487 | 222488 | 2023-04-30 | LOW |
Capital Research Global Investors | Investment Advisor | 1.9514 | 19171366 | 21003 | 2023-04-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.8817 | 18486575 | 77399 | 2023-04-30 | LOW |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 1.605 | 15767971 | -25042 | 2023-04-30 | LOW |
Dodge & Cox | Investment Advisor/Hedge Fund | 1.5086 | 14821176 | -6700 | 2023-03-31 | LOW |
Union Investment Privatfonds GmbH | Investment Advisor | 1.13 | 11101531 | 0 | 2022-12-31 | LOW |
Nuveen LLC | Pension Fund | 1.029 | 10109496 | 107466 | 2023-03-31 | LOW |
BlackRock Asset Management Deutschland AG | Investment Advisor | 0.9203 | 9040807 | 153707 | 2023-04-30 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.849 | 8340523 | -223114 | 2023-03-31 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.8276 | 8130854 | -85800 | 2023-04-30 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 0.8127 | 7983823 | -151 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.6831 | 6710712 | 42 | 2023-04-30 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 0.6592 | 6476031 | -4316765 | 2023-04-30 | MED |
Deka Investment GmbH | Investment Advisor/Hedge Fund | 0.6428 | 6314632 | -21437 | 2023-04-30 | LOW |
Schroder Investment Management Ltd. (SIM) | Investment Advisor/Hedge Fund | 0.5714 | 5613177 | -73568 | 2023-03-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.5634 | 5534693 | 90966 | 2023-04-30 | LOW |
Goldman Sachs Asset Management, L.P. | Investment Advisor | 0.5548 | 5450773 | -76579 | 2022-12-19 | LOW |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com Group530K+
Traders
87K+
Active clients monthly
$46M+
Monthly investing volume
$31M+
Withdrawn each month
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Bayer Company profile
Browse our live chart to get all the information you need on the Bayer share price today.
Bayer AG (BAYN) is a multinational pharmaceutical and life sciences company. Comprising over 350 companies, it operates as one of the world's largest chemical manufacturers. The business is producing and marketing innovative products in four core segments: human and veterinary pharmaceuticals; consumer healthcare products; agricultural chemicals, seeds and biotechnology products.
The company is headquartered in Leverkusen, Germany, and has operations in nearly every country in the world with a majority of its business in Europe, North America and the Far East. At the end of 2019, Bayer had a team of over 100,000 employees working worldwide. The firm is among industry leaders in research and development, spending nearly 12 per cent of its revenues on this segment.
The business is included in the Fortune Global 500 list of the world’s largest companies.
Bayer shares are listed on the Frankfurt Stock Exchange under the ticker symbol BAYN. The company is a constituent of the Euro Stoxx 50 Index and the DAX 30 Index.
Follow the ups and downs of the Bayer share price in euro with Capital.com to spot the best trading opportunities.
Founded in 1863, Bayer was part of chemicals giant IG Farben in 1925-52, and then returned to being an independent company. The new millennium saw the landmark acquisition of Schering in 2006 – the largest takeover in Bayer's history, and one of the biggest pharma mergers of all time. In September 2015, the company spun out its materials science division into a separate publicly-traded firm Covestro (1COV), retaining about a 70 per cent interest in the business.
On its website, Bayer explains that its innovative products are contributing to finding solutions to some of the world’s major challenges. The company says it is improving quality of life for a growing population by focusing its R&D on preventing, alleviating and treating diseases. It is also helping to provide a reliable supply of food, feed and plant-based raw materials.
In fact, this 150-year-old company was the first in the world to introduce the flagship healthcare product aspirin. Today, the firm manufactures products that include anti-infectives, antibiotics, oncology, cardiovascular, central nervous system drugs, over-the-counter medications, diagnostics and animal-health products, as well as crop protection products, plastics and polyurethanes.
With Capital.com’s Bayer stock chart you can not only quickly view the current Bayer share price, but also trace the company’s shares value in historic terms.
Bayer AG stock saw a period of almost uninterrupted growth from June 2012, when it traded at €46.87 per share, to April 2015, when it peaked at €143.88 per share. The stock then fell back to €82.79 per share in May 2016, right before recovering to hit €121.9 per share in 2017.
However, the uplift was short-lived, and BAYN stock soon started to lose in value sharply, falling as low as €52.21 per share by June 14, 2019. The share price then retraced some of its losses to end the year at €72.81. On March 23, 2020, the stock closed the trading day at its multi-year lowest of €47.5 per share amid the broader market sell off caused by the Covid-19 pandemic outbreak and consequent economic uncertainty.
Only a month later, in June 2020, BAYN shares were already hovering around the €70 level. Ever since, the Bayer stock price has experienced lots of volatility, characterised by multiple price fluctuations.
Stay up-to-date with the latest market news and watch the Bayer stock quote live at Capital.com.
Industry: | Pharmaceuticals (NEC) |
Kaiser-Wilhelm-Allee 1
LEVERKUSEN
NORDRHEIN-WESTFALEN 51373
DE
Income Statement
- Annual
- Quarterly
News

Google stock forecast 2023-2025
What is the outlook for the tech giant, following a tumultuous 2022?
18:02, 30 May 2023
USD forecast: DXY slides in risk-off market sentiment
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
16:10, 24 May 2023
Oil price forecast: Will WTI and Brent regain momentum in 2023?
Discover the drivers behind Brent and WTI volatility and get insights from analyst predictions.
11:38, 22 May 2023
Weekly Roundup: Tech stocks lead the way
US stocks push higher as risk appetite surges despite the uncertainty
13:39, 19 May 2023
USD/JPY continues to build higher towards 138
USD/JPY advances towards the top of its ascending triangle as the US dollar moves higher
11:50, 17 May 2023
Gold price predictions for next 5 years: Will gold continue rising?
The yellow metal reached near record-highs, yet will it maintain the momentum and for how long?
07:50, 17 May 2023
Gold price forecast: Will gold surpass record highs?
The US debt ceiling concerns and the banking crisis have been favourable for gold, yet is there more upside potential?
12:52, 16 May 2023People also watch
Still looking for a broker you can trust?
Join the 530.000+ traders worldwide that chose to trade with Capital.com